Literature DB >> 15166123

Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier.

Kimio Tohyama1, Hiroyuki Kusuhara, Yuichi Sugiyama.   

Abstract

The present study was aimed at investigating the involvement of mouse organic anion transporting polypeptide 14 (mOatp14) in the uptake of T4 across the blood-brain barrier. Functional expression of mOatp14 in HEK293 cells revealed that T4 and rT3 are high affinity substrates of mOatp14 (Michaelis constant, 0.34 and 0.46 microm, respectively), and the specific uptake of T3 was 4-fold less than that of T4 and rT3. Taurocholate, probenecid, and estrone-3-sulfate were moderate inhibitors for mOatp14, whereas digoxin (substrate of Oatp2), benzylpenicillin (substrate of Oat3), and large neutral amino acids had no effect. mOatp14 is widely expressed throughout the brain, except for the cerebellum. The expression of mOatp14 in the isolated brain capillaries and the choroid plexus was shown by Western blot. The uptake clearance of T4 by the cerebral cortex determined using the in situ brain perfusion technique in mice was 580 microl/min.g tissue, 3-fold greater than that by the cerebellum, and a saturable component (Michaelis constant, 1.0 microm) accounts for the major fraction of the total uptake. Taurocholate inhibited the uptake of T4 by the cerebral cortex completely, but the inhibition by estrone-3-sulfate was partial (50%). These results suggest that transporters play a predominant role in the delivery of T4 to the brain, and mOatp14 accounts for estrone-3-sulfate inhibitable fraction, at least partly. The absence of inhibition by digoxin, benzylpenicillin, leucine, and 2-aminobicyclo-(2,2,1)-heptane-2-carboxylic acid for the uptake of T4 by the cerebral cortex suggests the presence of other unknown transporter for T4 uptake by the brain. Immunohistochemical staining revealed basolateral localization of mOatp14 in the choroid plexus in which it may also play a role in T4 uptake.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15166123     DOI: 10.1210/en.2004-0058

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  42 in total

1.  Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumors.

Authors:  Laura B Jaeger; William A Banks; Jozsef L Varga; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-23       Impact factor: 11.205

Review 2.  Active efflux across the blood-brain barrier: role of the solute carrier family.

Authors:  Hiroyuki Kusuhara; Yuichi Sugiyama
Journal:  NeuroRx       Date:  2005-01

3.  Structural insights into thyroid hormone transport mechanisms of the L-type amino acid transporter 2.

Authors:  Katrin M Hinz; Katja Meyer; Anita Kinne; Ralf Schülein; Josef Köhrle; Gerd Krause
Journal:  Mol Endocrinol       Date:  2015-05-06

Review 4.  Drug transporters in the central nervous system.

Authors:  Bruno Stieger; Bo Gao
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

5.  Ex vivo perfusion of mid-to-late-gestation mouse placenta for maternal-fetal interaction studies during pregnancy.

Authors:  Nick Goeden; Alexandre Bonnin
Journal:  Nat Protoc       Date:  2012-12-13       Impact factor: 13.491

6.  Tissue distribution and thyroid hormone effects on mRNA abundance for membrane transporters Mct8, Mct10, and organic anion-transporting polypeptides (Oatps) in a teleost fish.

Authors:  Amanda M Muzzio; Pamela D Noyes; Heather M Stapleton; Sean C Lema
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2013-10-08       Impact factor: 2.320

Review 7.  Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport.

Authors:  Kousei Ito; Hiroshi Suzuki; Toshiharu Horie; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

8.  Membrane-traversing mechanism of thyroid hormone transport by monocarboxylate transporter 8.

Authors:  Jonas Protze; Doreen Braun; Katrin Manuela Hinz; Dorothea Bayer-Kusch; Ulrich Schweizer; Gerd Krause
Journal:  Cell Mol Life Sci       Date:  2017-01-28       Impact factor: 9.261

Review 9.  Autoimmune thyroid disease in pregnancy: a review.

Authors:  Juan C Galofre; Terry F Davies
Journal:  J Womens Health (Larchmt)       Date:  2009-11       Impact factor: 2.681

10.  Changes in the central component of the hypothalamus-pituitary-thyroid axis in a rabbit model of prolonged critical illness.

Authors:  Liese Mebis; Yves Debaveye; Björn Ellger; Sarah Derde; Eric-Jan Ververs; Lies Langouche; Veerle M Darras; Eric Fliers; Theo J Visser; Greet Van den Berghe
Journal:  Crit Care       Date:  2009-09-11       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.